Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication

Open Vet J. 2021; 11(3): 346-355


The potential anti- African swine fever virus effects of medium chain fatty acids on in vitro feed model: An evaluation study using a field ASFV strain isolated in Vietnam

Ha Thi Thanh Tran,Duc Anh Truong,Viet Duc Ly,Tuan Van Hoang,Nhu Thi Chu,Huyen Thi Nguyen,Anh Thi Kieu Dang,Maartje De Vos,Kobe Lannoo,Geert Bruggeman,Hoang Vu Dang.




Abstract
Cited by 4 Articles

Background: African swine fever (ASF) is an important disease affecting swine and has a significant economic loss on both the developed and developing world. Previous studies have indicated the mitigation of African swine fever virus (ASFV) in feed, suggesting that the risk of ASFV transmissibility via the oral exposure.
Aim: We evaluated the potential effects of MCFAs in both individual and synergistic forms, to prevent and/or reduce ASFV infection using in vitro feed model.
Methods: The cytotoxicity of MCFAs on PAM cells were evaluated by using the MTT assay. The potential effects of MCFAs, including C8, C6-C8-C10 (1:1:1 ratio) and C8-C10-C12 (1:1:1 ratio) against a field ASFV strain isolated in the Capital Hanoi of Vietnam were further examined by real-time PCR and HAD assays in in vitro feed model.
Results: Our results indicated that all products do not induce the cytotoxicity at the dose of 100 µg/ml and are suitable for further in vitro examination. All tested products have shown a strong antiviral effect against ASFV infectivity at doses of 0.375% and 0.5%. Interestingly, the synergistic MCFAs have shown clearly their potential activities against ASFV in which at lower dose of 0.25%, pre-treatment with product 2 and 3 induced significant increases at the level of Cq value when compared to positive control and/or product 1 (P

Key words: African swine fever virus; virus isolation; MCFA; pig; Vietnam






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.